SELLAS Life Sciences to Host Virtual Investor Symposium on its Lead Asset, Galinpepimut-S, on August 17, 2021

NEXT STORY
Global Clinical Microbiology Instruments and Reagents Market to Reach $6.1 Billion by 2027
PREV STORY
180 Life Sciences Announces Selection of Lead Synthetic CBD Analogue
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Positive results from Novartis five-year VERIFY study in type 2 diabetes demonstrate long-term clinical benefits of early combination treatment with Galvus® and metformin

author_avatar
NASDAQ Market News

Albireo Receives European Marketing Authorization of Bylvay™ (odevixibat), the First Drug Treatment for Progressive Familial Intrahepatic Cholestasis (PFIC)

author_avatar
NASDAQ Market News

The Sterile Gloves Market is expected to grow by $ 248.66 mn during 2021-2025, progressing at a CAGR of over 10% during the forecast period

author_avatar
NASDAQ Market News